CHICAGO & VIENNA–(BUSINESS WIRE)–GE HealthCare (Nasdaq: GEHC) today announced a global clinical evaluation program spanning three continents and five internationally recognized institutions to assess StarGuide™ GX,i its next-generation digital 4D SPECT/CT system. Participating institutions include Hadassah Medical Center in Israel; Mayo Clinic in the United States; Oncopole Claudius Regaud – Institut Universitaire du Cancer de Toulouse in France; Peking University First Hospital in China; and

LONDON–(BUSINESS WIRE)–  Re: GSK Capital B.V   EUR 850,000,000.00   MATURING: 07-Mar-2028   ISIN: XS3480669517     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 26-Aug-2026 TO 07-Dec-2026 HAS BEEN FIXED AT 2.84 PCT   DAY BASIS: ACTUAL/360   INTEREST PAYABLE VALUE 07-Dec-2026 WILL AMOUNT TO: EUR 6,899,426.39 PER EUR 850,000,000.00 DENOMINATION  

CINCINNATI–(BUSINESS WIRE)–ProAmpac, een wereldwijde marktleider op het gebied van flexibele verpakkingen en materiaalkunde, introduceert de ProActive Intelligence ™ Shelf Protect (SP)-serie. Dit biedt voedselproducenten een nieuwe manier om de productkwaliteit te behouden en kostbaar bederf te verminderen. De technologie is ontworpen voor specifieke toepassingen met vlees, vis en zuivelproducten en voldoet aan de FDA- en USDA-voorschriften voor gebruik bij vers rundvlees, vers varkensvlees,

LONDON–(BUSINESS WIRE)–Die weltweite Kartellrechtsdurchsetzung spaltet sich entlang nationaler Grenzen auf: 71 % der erfahrenen Wettbewerbsrechtler geben an, dass die Politik in den letzten 12 Monaten über die verschiedenen Rechtsordnungen hinweg fragmentierter geworden ist, so der erste Global Antitrust & Competition Report von BRG. Fast vier von fünf Befragten (78 %) nennen zudem grenzüberschreitende kartellrechtliche Anforderungen als erhebliche oder wiederkehrende Herausforderung. Der

LONDON–(BUSINESS WIRE)–  Re: Atlas Funding 2026-1 PLC   GBP 5,055,000.00   MATURING: 20-Jan-2068   ISIN: XS3346959649     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Sep-2026 TO 20-Oct-2026 HAS BEEN FIXED AT 9.74 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 20-Oct-2026 WILL AMOUNT TO: GBP .0 PER GBP 5,055,000.00 DENOMINATION  

LONDON–(BUSINESS WIRE)–  Re: ATLAS FUNDING 2023 -1 PLC   GBP 2,174,000.00   MATURING: 20-Jan-2061   ISIN: XS2601814754     PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 21-Sep-2026 TO 20-Oct-2026 HAS BEEN FIXED AT 13.47 PCT   DAY BASIS: ACTUAL/365(FIX)   INTEREST PAYABLE VALUE 20-Oct-2026 WILL AMOUNT TO: GBP 24,491.13 PER GBP 2,289,000.00 DENOMINATION  

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.